United BioSource (UBC) Acquires MarketShare Movers (MSM)

Making Science Group Acquires United Communications Partners, Inc.

August 26, 2024

Marketing & Advertising

Making Science Group, S.A., through its wholly owned subsidiary Making Science Marketing & Adtech, SLU (MSMA), has acquired all remaining common stock of United Communications Partners, Inc. (UCP) for cash consideration of $0.0029086 per share. UCP will become a wholly owned subsidiary of MSMA and continue operating within the Making Science group; UCP provides advertising, marketing and media services primarily across the Nordics and has approximately 75 employees there.

United BioSource (UBC) Acquires Examoto, LLC

July 28, 2022

Healthcare Services

United BioSource (UBC) has acquired Examoto, LLC, a provider of FDA-mandated REMS compliance platforms and risk-mitigation technology for the pharmaceutical industry. The acquisition expands UBC's REMS capabilities by combining Examoto's technology-driven REMS platform with UBC's scientific, safety, and commercialization services; terms were not disclosed.

MJH Life Sciences Acquires Pharmaceutical Commerce

July 9, 2020

Media & Entertainment

MJH Life Sciences has acquired Pharmaceutical Commerce, a multimedia B2B publication formerly published by Healthcare Commerce Media Corporation. The acquisition expands MJH’s healthcare media portfolio and strengthens its reach into the biopharma commercial operations and supply-chain audience, adding a magazine with a controlled circulation of roughly 21,000 and multiple newsletters and events.

United BioSource (UBC) Acquires Evidinno Outcomes Research

January 5, 2026

Healthcare Services

United BioSource LLC (UBC) has acquired Vancouver-based Evidinno Outcomes Research Inc., adding real-world evidence (RWE), epidemiology, evidence synthesis and HEOR capabilities to UBC's evidence-generation platform. Evidinno will operate as a wholly owned subsidiary of UBC; Fairmount Partners served as exclusive financial advisor to Evidinno.

Red Nucleus Acquires Medical Marketing Solutions Group (MMSG)

February 9, 2022

Healthcare Services

Red Nucleus, a Riverside-backed medical communications and scientific services provider, acquired Medical Marketing Solutions Group (MMSG) in February 2022 to expand its medical communications, publication planning, and conference management capabilities. The acquisition was completed as an add-on to the Red Nucleus platform, owned by The Riverside Company, broadening Red Nucleus’s therapeutic-area coverage and client relationships within biopharma.

Bora Pharmaceuticals Acquires Upsher-Smith Laboratories

August 5, 2025

Pharmaceuticals

Bora Pharmaceuticals completed a 2024 acquisition of Upsher-Smith Laboratories for $210 million and is expanding the Maple Grove, Minnesota manufacturing site with a multi-year buildout. The investment includes installation of a Gerteis Macro-Pactor (operational Q3 2025) and development of 100,000 square feet of shell space to boost oral solid dose (OSD) contract development and manufacturing capabilities.